Biopharma is facing increasing pressure to consistently deliver new, innovative products to patients, gain a competitive advantage, and meet greater stakeholder expectations. We're exploring how organisations need to change the way they operate, at both an enterprise as well as partnership level, to fully realise the potential of strategic partnerships and maximise impact for patients. Later this month, we'll be attending Patients as Partners Europe and the NEXT conference in Dubrovnik, as well as sharing our insights on how pharma companies can strategically partner with other organisations, healthcare professionals and patients to leverage their strengths, share risks, and unlock innovation. Find out more: https://ow.ly/xTzz50RvRMX #biotech #biopharma #pharma #lifesciences #pharmaceuticals #biotechnology Kate Moss (nee Watkins) Samantha Sierwald Joshua Elliott Chris Maxted
Interesting to see Baringa's Kate Moss (nee Watkins) Samantha Sierwald and Joshua Elliott discuss the potential of strategic partnerships in improving health outcomes in #pharma...
Pharmaceuticals and Life Sciences at Baringa
5moIt's fantastic to be able to share our focus for this year and can't wait to hear the insights from the discussions we will be hosting at #PatientsasPartners #NEXT conferences, as well as sharing our perspectives on #Strategic #Partnerships very soon!